EXACT SCIENCES CORP (EXAS) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
EXAS currently has 189M outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 2.99% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Nov 03, 2025 |
10-Q filing | 189.3M shares outstanding |
190M | 0 |
| Aug 06, 2025 |
10-Q filing | 188.9M shares outstanding |
190M | 0 |
| May 01, 2025 |
10-Q filing | 186.8M shares outstanding |
190M | 0 |
| Feb 19, 2025 |
10-K filing | 184.2M shares outstanding |
180M | 0 |
| Nov 05, 2024 |
10-Q filing | 184.8M shares outstanding |
180M | 0 |
| Jul 31, 2024 |
10-Q filing | 184.3M shares outstanding |
180M | 0 |
| May 08, 2024 |
8-K filing: Exact Sciences Corporation filed a prospectus supplement to register the resale of up to 5,570,132 shares of the Company's common stock by selling stockholders. |
180M | 0 |
| May 08, 2024 |
10-Q filing | 182.4M shares outstanding |
180M | 0 |
| Feb 21, 2024 |
10-K filing | 180.1M shares outstanding |
180M | 0 |
| Nov 01, 2023 |
10-Q filing | 180.6M shares outstanding |
180M | 0 |
| Aug 01, 2023 |
10-Q filing | 180.2M shares outstanding |
180M | 0 |
| May 09, 2023 |
10-Q filing | 178.6M shares outstanding |
180M | 0 |
| Mar 17, 2023 |
8-K filing: Exact Sciences Corporation filed a prospectus supplement to register the resale of up to 5,171,577 shares of the company's common stock by selling stockholders. |
180M | 0 |
| Feb 21, 2023 |
10-K filing | 176.4M shares outstanding |
180M | 0 |
| Nov 03, 2022 |
10-Q filing | 177.0M shares outstanding |
180M | 0 |
| Aug 02, 2022 |
10-Q filing | 176.4M shares outstanding |
180M | 0 |
| Apr 26, 2022 |
10-Q filing | 174.4M shares outstanding |
170M | 0 |
| Feb 22, 2022 |
10-K filing | 171.3M shares outstanding |
170M | 0 |
| Nov 02, 2021 |
10-Q filing | 172.0M shares outstanding |
170M | 0 |
| Jul 28, 2021 |
10-Q filing | 171.5M shares outstanding |
170M | 0 |
| May 04, 2021 |
10-Q filing | 171.6M shares outstanding |
170M | 0 |
| Feb 16, 2021 |
10-K filing | 169.1M shares outstanding |
170M | 0 |
| Jan 05, 2021 |
8-K filing: Exact Sciences Corporation completed the acquisition of Thrive, issuing 9,323,266 shares of common stock and converting Thrive stock options, restricted stock awards and restricted stock units into Company stock options, restricted stock awards and restricted stock units covering a total of 1,635,871 shares of Company common stock. |
150M | 0 |
| Oct 27, 2020 |
10-Q filing | 150.4M shares outstanding |
150M | 0 |
| Jul 31, 2020 |
10-Q filing | 150.2M shares outstanding |
150M | 0 |
| May 06, 2020 |
10-Q filing | 149.7M shares outstanding |
150M | 0 |
| Feb 21, 2020 |
10-K filing | 148.0M shares outstanding |
150M | 0 |